Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 22, 2012

Prosolia, AB Sciex Obtain License for ORNL Analytical Technology

  • Prosolia and AB Sciex entered into a license agreement for technologies developed by Gary Van Berkel, Ph.D., and his colleagues at Oak Ridge National Laboratory (ORNL). The arrangement provides Prosolia a license to a portfolio of new sample introduction and ionization methods based on the liquid microjunction surface sampling probe approach that enables direct extraction of solid-phase analytes from a variety of surfaces using a continuous flow of solvent.

    Its advantages provide research scientists and technicians access to rapid sample analyses in combination with multimodal ionization capabilities and the versatility of coupling to thin-layer and liquid chromatography techniques. “We envision several new products arising out of Dr. Van Berkel's inventions and are excited to work with him and his group on these projects,” says Justin Wiseman, president and CEO of Prosolia. 

    “We are delighted that our collaboration with thought leaders at Oak Ridge National Laboratory continues to be validated by the growing interest across the life science industry,” remarks Dave Hicks, vp of the pharma and academic business, AB Sciex. “Licensing the technology to other companies such as Prosolia will help speed up the commercialization of this novel sampling innovation.”

    Prosolia’s flagship product is based on desorption electrospray ionization (DESI) technology. DESI enables rapid spot sampling and chemical imaging of surfaces under ambient conditions using mass spectrometry. The company’s current products retro-fit onto instruments produced by the major instrument companies including AB Sciex, Thermo Scientific, Waters, Agilent, Bruker, and LECO.

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »